Table 6.
Comparison of LDL-C target achievement between those who completed CR in 2019 with the EUROASPIRE and DAVINCI studies
| Number of ‘very high risk’ patients (n) | Age (SD)* | Female | LDL-C target achieved |
|---|---|---|---|
| CR 2019 (n = 142) | 62 (10) | 40 (25) | 96 (59) |
| 2016 Guidelines (n = 99) | 63 (9) | 14 (28) | 70 (63) |
| 2019 Guidelines (n = 43) | 61 (11) | 26 (23) | 26 (51) |
| EUROASPIRE Va (n = 8261) | 62.5 (9.6) | 62.5 (9.6) | 2396 (29) |
| DAVINCIa (n = 2039) | 68 (10) | 68 (10) | 795 (39) |
| Primary care (n = 526) | 188 (35) | ||
| Secondary care (n = 1513) | 620 (41) |
Table 6 compares absolute LDL-C target achievement between those that completed cardiac rehabilitation in 2019 with those examined in the EUROASPIRE V and DAVINCI studies. Unless where otherwise stated, values are given as the number with the percentage of the total sample size in brackets
Primary care = primary care practitioner only. Secondary care = regular attendance with a cardiologist, diabetologist or endocrinologist
*Values are displayed as mean (SD)
aBoth studies were conducted using the 2016 ESC guidelines